StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Wave Life Sciences's profit margin for the twelve months ending Sep 30, 2026 was -296.9%. For fiscal 2025 it was -478.3%, against -89.6% the year before. The highest annual figure on record is -50.8% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-478.3%−388.8
FY2024Dec 31, 2024-89.6%−38.8
FY2023Dec 31, 2023-50.8%+4384.0
FY2022Dec 31, 2022-4434.7%−4136.3
FY2021Dec 31, 2021-298.4%+448.3
FY2020Dec 31, 2020-746.7%+464.8
FY2019Dec 31, 2019-1211.5%−194.1
FY2018Dec 31, 2018-1017.4%+1602.1
FY2017Dec 31, 2017-2619.6%+2477.5
FY2016Dec 31, 2016-5097.1%+7534.5
FY2015Dec 31, 2015-12631.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-470.5%+237.3
Q2 FY2026Jun 30, 2026-3052.6%−2472.4
Q1 FY2026Mar 31, 2026-68.2%+442.7
Q4 FY2025Dec 31, 2025-308.4%−141.2
Q3 FY2025Sep 30, 2025-707.8%−456.1
Q2 FY2025Jun 30, 2025-580.2%−524.2
Q1 FY2025Mar 31, 2025-510.9%−525.7
Q2 FY2024Jun 30, 2024-167.2%−71.7
Q1 FY2024Mar 31, 2024-251.7%−39.7
Q4 FY2023Dec 31, 2023-55.9%+3471.8
Q3 FY2023Sep 30, 202314.7%+13700.3
Q2 FY2023Jun 30, 2023-95.5%+10916.8
Q1 FY2023Mar 31, 2023-212.0%+1948.8
Q4 FY2022Dec 31, 2022-3527.8%−1556.9
Q3 FY2022Sep 30, 2022-13685.6%−13668.5
Q2 FY2022Jun 30, 2022-11012.3%−9615.8
Q1 FY2022Mar 31, 2022-2160.8%−1855.8
Q4 FY2021Dec 31, 2021-1970.8%−1011.4
Q3 FY2021Sep 30, 2021-17.1%+1321.8
Q2 FY2021Jun 30, 2021-1396.5%−255.1
Q4 FY2020Dec 31, 2020-305.0%+2060.4
Q3 FY2020Sep 30, 2020-959.4%+772.4
Q2 FY2020Jun 30, 2020-1338.9%−789.0
Q1 FY2020Mar 31, 2020-1141.4%+319.3
Q4 FY2019Dec 31, 2019-2365.4%−1318.8
Q3 FY2019Sep 30, 2019-1731.9%−894.3
Q2 FY2019Jun 30, 2019-549.8%+185.8
Q1 FY2019Mar 31, 2019-1460.7%+1017.6
Q4 FY2018Dec 31, 2018-1046.6%+1757.9
Q3 FY2018Sep 30, 2018-837.5%+1101.2
Q2 FY2018Jun 30, 2018-735.7%+1506.5
Q1 FY2018Mar 31, 2018-2478.3%+3029.8
Q4 FY2017Dec 31, 2017-2804.5%−74.6
Q3 FY2017Sep 30, 2017-1938.7%–
Q2 FY2017Jun 30, 2017-2242.2%–
Q1 FY2017Mar 31, 2017-5508.1%–
Q4 FY2016Dec 31, 2016-2729.9%–

More Wave Life Sciences figures

See a number that looks wrong?